Ramipril

Other ACE inhibitors have had less than additive effects with beta adrenergic blockers, presumably because both drug classes lower blood pressure by inhibiting parts of the renin-angiotensin-aldosterone system.

المصدر: FDA openFDA

The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ramipril.

The risk or severity of angioedema can be increased when Ramipril is combined with Alteplase.

The risk or severity of angioedema can be increased when Anistreplase is combined with Ramipril.

Cyclosporine may decrease the antihypertensive activities of Ramipril.

Desmopressin may decrease the antihypertensive activities of Ramipril.

The serum concentration of Erythropoietin can be decreased when it is combined with Ramipril.

The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Icosapent is combined with Ramipril.

The risk or severity of hypoglycemia can be increased when Ramipril is combined with Insulin glargine.

The risk or severity of hypoglycemia can be increased when Ramipril is combined with Insulin human.